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bjectives This study aimed to validate the SYNTAX (Synergy between PCI with Taxus and Cardiac
urgery) score representing angiographic complexity after unprotected left main coronary artery
ULMCA) revascularization.
ackground The validity of the SYNTAX score has been adequately evaluated.
ethods The SYNTAX scores were calculated for 1,580 patients in a large multicenter registry who
nderwent percutaneous coronary intervention (PCI) (n  819) or coronary artery bypass graft
CABG) (n  761) for ULMCA stenosis. The outcomes of interests were 3-year incidences of major
dverse vascular events (MAVE), including death, Q-wave myocardial infarction, and stroke and ma-
or adverse cardiac and cerebrovascular events (MACCE), including MAVE and target vessel revascu-
arization of ULMCA.
esults The incidence of 3-year MAVE was 6.2% in the lowest (23), 7.1% in the intermediate
23 to 36), and 17.4% in the highest (36) SYNTAX score tertile groups after PCI (p  0.010).
owever, the incidences of MAVE in the CABG group and MACCE in the PCI and CABG groups did
ot differ among the SYNTAX tertiles. In subgroups, the MAVE (p  0.005) and MACCE (p  0.007)
ates according to the SYNTAX score tertiles were signiﬁcantly different in patients receiving drug-
luting stent, not in those receiving bare-metal stent. When compared with the clinical EuroSCORE
European System for Cardiac Operative Risk Evaluation), the C-indexes of SYNTAX score and Euro-
CORE were 0.59 and 0.67, respectively, for discrimination of MAVE and 0.53 and 0.57, respectively,
or MACCE.
onclusions The angiographic SYNTAX score seems to play a partial role in predicting long-term
dverse events after PCI for ULMCA stenosis. A complementary consideration of patient’s clinical risk
ight improve the predictive ability of risk score. (J Am Coll Cardiol Intv 2010;3:612–23) © 2010 by
he American College of Cardiology Foundation
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613he introduction of drug-eluting stents (DES), together
ith advances in peri- and post-procedural adjunctive phar-
acotherapies, has improved outcomes of percutaneous
oronary interventions (PCI) for unprotected left main
oronary artery (ULMCA) stenosis (1–15). Therefore, PCI
ith stenting is now considered a viable alternative to
oronary artery bypass graft (CABG) surgery (2,6,10,16).
tandard guidelines, however, still recommend PCI for
atients with ULMCA stenosis at high surgical risk or in
mergency clinical situations, such as bailout procedures or
or treatment of acute myocardial infarction (MI), because
ecent findings have failed to show that DES placement is
uperior or at least noninferior to CABG with respect to
ffectiveness of repeat revascularization (10,17,18).
See page 642
Several risk scores have been developed to stratify patients
t high risk of revascularization for ULMCA or multivessel
tenosis (17,19,20). One such, the SYNTAX (Synergy
etween PCI with Taxus and Cardiac Surgery) score, was
ormulated to comprehensively represent angiographic com-
lexity, which is considered an important determinant of
utcomes after PCI or CABG for treatment of multivessel
oronary disease (17,21,22). When the score was intrinsi-
ally applied to patients enrolled in the SYNTAX random-
zed trial, which compared DES with CABG in patients
ith multivessel disease, a lower incidence of adverse events
fter CABG was observed only in the highest SYNTAX
core tertile group (17). This finding suggested the role of
YNTAX score in predicting differential outcomes of stent-
ng versus CABG for complex coronary lesions. This score,
owever, should be validated in a large external cohort so
hat the SYNTAX score can be more widely applied to
redict ULMCA revascularization.
We sought to validate the SYNTAX score by measure-
ents of discrimination and calibration for 3-year outcomes
f patients enrolled in revascularization procedures for
nprotected left main coronary artery stenosis, with the
AIN-COMPARE (COMparison of Percutaneous coro-
ary Angioplasty versus surgical REvascularization) registry
f patients undergoing PCI or CABG for ULMCA stenosis
10). Furthermore, its discriminatory power was compared
ith the EuroSCORE (European System for Cardiac
perative Risk Evaluation), which has been considered an
mportant clinical risk score to predict outcomes in patients
ndergoing CABG or PCI (19,20,23).
ethods
he MAIN-COMPARE study enrolled patients with
LMCA stenosis (50% narrowing) who underwent either
ABG or PCI as the index procedure at 12 major cardiacenters in Korea between January 2000 and June 2006 (10). dhe left main was considered unprotected if there were no
atent grafts to the left anterior descending or circumflex
rteries. Patients who had undergone previous CABG,
hose who underwent concomitant valvular or aortic sur-
ery, and those who had ST-segment elevation MI or
resented with cardiogenic shock were excluded. The insti-
utional review board at each hospital approved the use of
linical data for this study, and all patients provided written
nformed consent. The authors had full access to the data
nd take full responsibility for their integrity. All authors
ave read and agree to the report as written.
rocedures and follow-up. The PCI and CABG procedure
ave been described (10). For PCI, the selection of stent,
djunctive device, and medication was at the operator’s
iscretion. After 2003, DES, either sirolimus- (Cypher,
ordis Corporation, Johnson & Johnson, Miami Lakes,
lorida) or paclitaxel-eluting (Taxus, Boston Scientific,
atick, Massachusetts) stents,
ere used as the default stent in
ll institutions. For CABG, the
nternal thoracic artery was first
ttempted to use for revascu-
arization of the left anterior
escending artery. Clinical, an-
iographic, procedural, and
utcome data were collected and
djudicated centrally. Informa-
ion about vital status was ascer-
ained from the National Popu-
ation Registry of the Korea
ational Statistical Office. Rou-
ine angiographic follow-up at 6
o 10 months after the procedure
as recommended for all pa-
ients undergoing PCI, but not
ABG. The EuroSCORE,
omposed of groups of weighted
atient-oriented, cardiac-related, and surgery-related fac-
ors, was reported in a simple additive form from individual
ites and examined centrally (19).
The primary end point of the study was the incidence of
ajor adverse vascular events (MAVE), defined as the
omposite of death, Q-wave MI, and stroke, which reflected
he safety of treatment. The secondary end point was the
ncidence of major adverse cardiac and cerebrovascular
vents (MACCE), a composite consisting of all the com-
onents of MAVE plus target vessel revascularization
TVR) at ULMCA, which reflected the effectiveness of
reatment. Death was defined as death from any cause.
-wave MI was defined as documentation of a new abnor-
al Q-wave after index treatment. Stroke, indicated by
eurologic deficits, was confirmed by a neurologist on the
asis of imaging analyses. The TVR at ULMCA was
Abbreviations
and Acronyms
BMS  bare-metal stent(s)
CABG  coronary artery
bypass graft
DES  drug-eluting stent(s)
MACCE  major adverse
cardiac and cerebrovascular
events
MAVE  major adverse
vascular events
MI  myocardial infarction
PCI  percutaneous
coronary intervention
TVR  target vessel
revascularization
ULMCA  unprotected left
main coronary arteryefined as repeat revascularization of the treated vessel,
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The SYNTAX Score for LM Revascularization
614ncluding any segment of the left anterior descending artery,
eft circumflex artery, or ULMCA.
ngiographic measurement. To measure each SYNTAX
core, a baseline angiogram obtained before the procedure
as retrospectively collected for each of 1,580 (70.5%)
atients from the overall cohort of the MAIN-COMPARE
egistry. A calculation of the SYNTAX score was based on
he algorithm, which was the sequential morphological
valuation of dominance; number of lesions; segments
nvolved/lesion; and presence of total occlusion, trifurcation,
ifurcation, aorto-ostial lesion, severe tortuosity, long lesion
20 mm), heavy calcification, thrombus, and diffuse/small
essels in the ULMCA and concomitant lesions for each
atient (21). The score was independently analyzed with
edicated angiographic software (CASS-5, Pie-Medical,
aastricht, the Netherlands) by 6 angiographers in the
ngiographic core laboratory (CardioVascular Research
oundation, Seoul, Korea). To decrease interobserver vari-
tion, the scores measured by individual angiographers were
andomly monitored and reviewed by a senior angiographer.
n case of disagreement, consensus was made within the
roup. Furthermore, to assess the reliability of score mea-
urement in the core lab, we examined interexaminer
eliabilities with the intraclass correlation coefficient for
uantitative variables of the SYNTAX score. The intraclass
orrelation coefficient for 20 patients, who were randomly
elected from the MAIN-COMPARE registry and were
easured by 6 angiographers, was 0.69 before this study. A
oefficient0.4 was considered poor agreement; 0.4 to 0.59
as considered fair; 0.6 to 0.75 was considered good; and
0.75 was considered excellent (24).
tatistical analysis. Baseline demographic, clinical, and an-
iographic characteristics were reported as medians with
nterquartile ranges for continuous variables and as numbers
nd percentages for categorical variables. Continuous vari-
bles were compared between 2 groups with the Mann-
hitney U test, whereas the Kruskal-Wallis test was used
or multiple group comparisons. Categorical variables were
ompared with the chi-square test or Fisher exact test, as
ppropriate. The normality assumption for the SYNTAX
core was evaluated by the Kolmogorov-Smirnov test.
To validate the SYNTAX score and the ability of the
core to predict primary and secondary end points, measures
f discrimination and calibration were examined (25). To
ssess discrimination ability, which refers to the power to
istinguish between patients with and without events for 3
ears, the C-index method was used (26). A value of 0.5
epresents no weighting, whereas values between 0.7 and 0.9
ere useful in predictive models (27). We also compared the
isk model fit by use of the Akaike Information Criterion,
hich is a measure based on the log likelihood function, and
low value implies a better fit (28). The slopes of the linear
redictors (shrinkage) were separately computed (29) to
alibrate the 2 models of SYNTAX score and Euro- wCORE. The slope of the predictor is a measure of how
ell the predicted probability reflected observed probabili-
ies. A score of 1.0 represents full agreement, whereas lower
cores represent poorer concordance. Furthermore, to test
he additive role of clinical EuroSCORE, we repeated the
nalyses of calibration and discrimination after adding the
erm of EuroSCORE into the model for SYNTAX score.
he differences in the C-index between the SYNTAX score
nd EuroSCORE were obtained through bootstrap with
ercentile method (200 replicates) (30). Moreover, to test
he differential effect of PCI versus CABG on long-term
utcomes for subgroups stratified by SYNTAX score tertile,
e used the Kaplan-Meier method and compared the
rimary and secondary end points of the 2 strategies with
he log-rank test. Interactions between factors associated
ith treatment type and SYNTAX score tertiles were tested
y incorporation of formal interaction terms in a multivar-
ate Cox model. Finally, additional multivariate Cox pro-
ortional hazard regression models were created to identify
actors independently contributing to outcomes. Propor-
ional hazards assumptions were confirmed by Schoenfeld’s
ests, and no relevant violation was found. In our multivar-
ate models, the potential confounders were adjusted by
ackward elimination until variables with only p values
0.1 remained. To avoid overfitting problem caused by the
imited number of events, we restricted the number of
ovariates, including age (year), male sex, hypertension,
iabetes mellitus, hyperlipidemia, smoking, prior PCI, pre-
ious MI, chronic lung disease, cerebral or peripheral
ascular disease, chronic renal failure, congestive heart
ailure, family history of coronary artery disease, acute
oronary syndrome, number of extra-ULMCA diseased
essels, number of diseased segments according to the
YNTAX classification, left anterior descending artery ste-
osis, left circumflex stenosis, right coronary stenosis,
LMCA bifurcation stenosis, aorto-ostial ULMCA steno-
is, ostial left circumflex artery stenosis, treatment type
CABG vs. PCI), EuroSCORE, and SYNTAX score.
All p values were 2-sided, and p values 0.05 were
egarded as statistically significant. The SAS software ver-
ion 9.1 (SAS Institute, Cary, North Carolina) and the
programming language with Design library were used for
tatistical analysis.
esults
aseline and procedural characteristics. We evaluated a
otal of 1,580 patients, 819 (51.8%) undergoing PCI and
61 (48.2%) undergoing CABG. Clinical and angiographic
haracteristics are shown in Tables 1 and 2. The SYNTAX
core was not normally distributed, and its median value was
0.0 (Fig. 1). When patients were stratified by SYNTAX
core tertiles, the cutoff points were 23 and 36. Compared
ith patients in the lowest SYNTAX score tertile, those in
Table 1. Clinical Characteristics of Patients According to SYNTAX Score Tertiles
Lowest (<23) Intermediate (>23 and <36) Highest (>36) p Value*
Variable
PCI
(n  435)
CABG
(n  112) p Value
PCI
(n  268)
CABG
(n  243) p Value
PCI
(n  116)
CABG
(n  406) p Value PCI Group CABG Group
Age (yrs) 58.5 (49.0–65.8) 59.7 (53.4–69.4) 0.081 66.6 (58.4–72.2) 63.1 (57.0–67.9) 0.001 67.1 (57.9–75.5) 65.3 (58.4–70.3) 0.029 0.001 0.001
Male sex (%) 288 (66.2) 84 (75.0) 0.075 199 (74.3) 179 (73.7) 0.88 33 (28.4) 109 (26.8) 0.73 0.070 0.93
Diabetes mellitus 96 (22.1) 27 (24.1) 0.65 103 (38.4) 79 (32.5) 0.16 50 (43.1) 155 (38.2) 0.34 0.001 0.016
Hypertension 185 (42.5) 48 (42.9) 0.95 162 (60.4) 118 (48.6) 0.007 68 (58.6) 216 (53.2) 0.30 0.001 0.13
Hyperlipidemia 125 (28.7) 26 (23.2) 0.24 87 (32.5) 84 (34.6) 0.61 46 (39.7) 172 (42.4) 0.60 0.073 0.001
Current smoker 117 (26.9) 40 (35.7) 0.066 62 (23.1) 81 (33.3) 0.010 16 (13.8) 104 (25.6) 0.008 0.012 0.035
Previous PCI 72 (16.6) 15 (13.4) 0.42 67 (25.0) 29 (11.9) 0.001 21 (18.1) 34 (8.4) 0.003 0.021 0.17
Previous MI 27 (6.2) 9 (8.0) 0.49 25 (9.3) 25 (10.3) 0.72 16 (13.8) 48 (11.8) 0.57 0.024 0.50
Previous heart failure 7 (1.6) 3 (2.7) 0.45 5 (1.9) 6 (2.5) 0.64 5 (4.3) 15 (3.7) 0.76 0.19 0.66
Chronic obstructive pulmonary disease 9 (2.1) 4 (3.6) 0.32 6 (2.2) 3 (1.2) 0.51 1 (0.9) 11 (2.7) 0.48 0.65 0.32
Cerebrovascular disease 25 (5.7) 3 (2.7) 0.19 25 (9.3) 19 (7.8) 0.54 14 (12.1) 36 (8.9) 0.30 0.042 0.09
Peripheral vascular disease 6 (1.4) 6 (5.4) 0.010 2 (0.7) 10 (4.1) 0.012 4 (3.4) 29 (7.1) 0.15 0.13 0.28
Chronic renal failure 7 (1.6) 3 (2.7) 0.45 11 (4.1) 5 (2.1) 0.19 5 (4.3) 19 (4.7) 0.87 0.086 0.19
Ejection fraction (%) 63.0 (58.0–68.0) 63.0 (56.0–67.0) 0.33 61.0 (55.0–67.0) 61.0 (55.0–66.0) 0.67 59.5 (52.3–65.0) 58.0 (48.0–64.0) 0.33 0.001 0.001
Atrial ﬁbrillation 8 (1.8) 3 (2.7) 0.70 7 (2.6) 10 (4.1) 0.34 3 (2.6) 6 (1.5) 0.42 0.76 0.11
Acute coronary syndrome 288 (66.2) 73 (65.2) 0.84 160 (59.7) 178 (73.3) 0.001 70 (60.3) 337 (83.0) 0.001 0.17 0.001
Family history of coronary disease 36 (8.3) 16 (14.3) 0.053 16 (6.0) 28 (11.5) 0.025 7 (6.0) 42 (10.3) 0.16 0.45 0.50
EuroSCORE 3.0 (2.0–5.0) 3.0 (2.0–5.0) 0.063 4.0 (2.0–5.0) 4.0 (3.0–5.0) 0.97 4.0 (3.0–6.0) 5.0 (3.0–6.0) 0.086 0.001 0.001
Values are presented as median (interquartile range) or n (%). *p Values among 3 groups stratified by SYNTAX (Synergy between PCI with Taxus and Cardiac Surgery) score tertiles within the stenting or coronary artery bypass graft (CABG) group.
EuroSCORE European System for Cardiac Operative Risk Evaluation; MImyocardial infarction; PCI percutaneous coronary intervention.
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616he highest tertile were likely to be elderly persons and to
ave more coronary risk factors, unstable manifestations,
xtensive coronary involvement, high EuroSCORE, and
ifurcation ULMCA stenosis. In the PCI group, the
umbers of patients with the highest, intermediate, and
owest SYNTAX scores were 111, 44, and 19, respectively,
n patients receiving bare-metal stent (BMS) and 324, 224,
nd 97, respectively, in those receiving DES.
When angiographic characteristics were compared be-
ween PCI and CABG groups in the 3 SYNTAX score
ertiles, we found that the CABG group was more likely to
ave more extensive coronary involvement than the PCI
roup. However, the differences in clinical characteristics
ere heterogeneous between the 2 treatments across the
arious subgroups.
-year outcomes. When follow-up was censored at 3 years,
ollow-up was completed in 1,508 (95.4%) patients. For the
-year period, the Kaplan-Meier incidence of death,
AVE, and MACCE in the PCI and CABG groups were
.2% versus 9.2% (p  0.021), 7.1% versus 10.4% (p 
.020), and 17.4% versus 13.1% (p  0.016), respectively.
igure 2 shows the 3-year Kaplan-Meier incidences of
AVE and MACCE for overall patients stratified by the
YNTAX score tertiles. Figure 3 shows the incidences of
AVE and MACCE in patients receiving PCI and
ABG, for subgroups stratified by SYNTAX score tertiles.
he differences in event rates among the groups stratified by
YNTAX score tertiles were statistically significant for
AVE in the PCI (p  0.010) but not for MAVE in the
ABG (p  0.293) and MACCE in the PCI (p  0.080)
Figure 1. Distribution, Mean, and Median Values of the SYNTAX Score
The score was not normally distributed by Kolmogorov-Smirnov test (p 
0.001). Mean: 30.9, standard deviation: 14.2, median 30.0, interquartile
range: 19 to 40, tertile group: 23, 23 and 36, 36. SYNTAX  Synergy
between PCI with Taxus and Cardiac Surgery.and CABG (p  0.594) groups. The interaction betweenT S N N E L
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617reatment type and SYNTAX score tertiles was not signif-
cant with regard to the risk of MAVE (p  0.25) or
ACCE (p  0.66).
When the PCI group was separated into patients receiv-
ng BMS or DES, the 3-year incidences of MAVE (p 
.005) and MACCE (p  0.007) according to the
YNTAX score tertiles were significantly different in the
ES group (Fig. 4). However, the difference of MAVE
p 0.18) or MACCE (p 0.49) rates did not differ in the
MS group. The interaction between treatment type and
YNTAX score tertiles was not significant with regard to
he risk of MAVE (p  0.20, BMS vs. CABG; p  0.17,
ES vs. CABG) or MACCE (p  0.39, BMS vs. CABG;
 0.29, DES vs. CABG).
iscrimination and calibration. The median EuroSCORE
as 4.0 (interquartile range: 2 to 6). Table 3 summarizes
he results of discrimination and calibration of the
YNTAX score as compared with the EuroSCORE. In
iscriminating between CABG and PCI with a primary
nd point of MAVE, the SYNTAX score was less
redictive than the EuroSCORE, as indicated by the
ower C-indexes in all subgroups (p  0.0123 in overall
atients, p  0.89 in the PCI group, and p  0.001 in
ABG group). Consequently, the Akaike Information
riterion was lower with the EuroSCORE than the
YNTAX score, indicating that the former is a better
redictive model. The slope of the linear predictor was
loser to 1.00 when using EuroSCORE rather than
YNTAX score, indicating that the former model was
Figure 2. Kaplan-Meier Incidence Curves of Outcomes in Overall Patients
Three-year event rates of death, Q-wave myocardial infarction, or stroke (A); an
ization (B) for patients with the lowest (Low), intermediate (Int), and highest (H
groups.etter calibrated. Regarding the secondary end point of sACCE, both the SYNTAX score and the EuroSCORE
ad C values lower than 0.6 in the PCI group, indicating
hat their predictive abilities were weak. The differences of
values between the 2 scores were statistically significant in
he CABG group (p  0.001), but not in the PCI group
p  0.18) and overall patients (p  0.083). When the
uroSCORE and SYNTAX score were combined, the
alues of the C-index and the Akaike Information Criterion
or the risk of MAVE and MACCE were slightly increased,
ndicating an improvement of predictive ability.
ultivariable analysis. When multivariate Cox regression
odels were formulated, clinical characteristics of patients
nd EuroSCORE were independent predictors of MAVE
r MACCE (Table 4). However, the SYNTAX score was
ot an independent predictor in any model.
iscussion
good risk-scoring model is considered to be valuable in
redicting outcomes and guiding a selection of appropriate
reatment strategies for patients with complex coronary
esions. However, because of the lack of clinical studies
elevant to development of a risk model applicable to PCI,
uroSCORE—which was created for patients undergoing
pen-heart surgery—has often been used as a clinical risk
ndex to represent clinical complexity of patients receiving
CI or CABG for ULMCA stenosis (1,15,20,31). Appli-
ation of EuroSCORE to PCI procedures, however, is
nherently limited because the score was designed to assess
es of death, Q-wave myocardial infarction, stroke, or target vessel revascular-
SYNTAX (Synergy between PCI with Taxus and Cardiac Surgery) score tertiled rat
igh)urgical risk. As a result, new risk scores, such as the Mayo
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618linic Risk Score or Texas Heart Institute Risk Score, were
reated for a better prediction of outcomes after complex
CI (32,33). In the meantime, the SYNTAX score, which
as basically developed to characterize angiographic com-
lexity, has been proposed to predict outcomes and select an
ptimal treatment strategy, whether PCI or CABG (22,34).
The effectiveness of the SYNTAX score was firstly
ssessed in the ARTS II (Arterial Revascularization Ther-
pies Study part II) trial, which enrolled patients with
Figure 3. Kaplan-Meier Incidence Curves of Outcomes
Three-year event rates of death, Q-wave myocardial infarction, or stroke for pa
between PCI with Taxus and Cardiac Surgery) score tertile groups between the
death, Q-wave myocardial infarction, stroke, or target vessel revascularization f
tertile groups between the stent and CABG groups.ultivessel coronary disease (34). The SYNTAX score Chowed a better ability to predict the initial and long-term
isks of MACCE when compared with the previous angio-
raphic classification of the American College of Cardiol-
gy/American Heart Association. Subsequently, studies in
atients with ULMCA stenosis supported the effectiveness
f the SYNTAX score in predicting mortality after PCI or
ABG (35,36) or myonecrosis after PCI (37). The other
tudies, however, found that the SYNTAX score was poor
hen used to predict long-term mortality or TVR after
with the lowest (A), intermediate (B), and highest (C) SYNTAX (Synergy
and coronary artery bypass graft (CABG) groups. Three-year event rates of
ients with the lowest (D), intermediate (E), and highest (F) SYNTAX scoretients
stent
or patABG or DES implantation (38). Generalization of these
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619esults assessing the role of the SYNTAX score, however, is
imited by small sample sizes, variations in follow-up time,
r selected patient enrollment. In this regard, the present
tudy is unique in seeking to validate the scoring system
ith the largest available external database on consecutive
atients undergoing PCI or CABG for ULMCA stenosis,
ith information filed in a national multicenter registry.
We found that the SYNTAX score was weakly predictive
f a risk of 3-year MAVE—a composite of safety end
oints—in patients undergoing PCI, as indicated by the
-index value of 0.63. In particular, the score showed a
Figure 4. Kaplan-Meier Incidence Curves of Outcomes
Three-year event rates of death, Q-wave myocardial infarction, or stroke for pa
ergy between PCI with Taxus and Cardiac Surgery) score tertile groups in patie
rates of death, Q-wave myocardial infarction, stroke, or target vessel revascula
metal stent (B) and drug-eluting stent (D).tronger predictability when applied to patients receiving cES, having the higher C-index value of 0.66. Likewise,
egarding a risk of MACCE, the score was still weakly
redictive after DES treatment but not after BMS treat-
ent. This finding was in good agreement with the previous
tudies showing the benefit of SYNTAX score in predicting
ong-term outcomes after PCI with DES for multivessel or
LMCA stenosis (34,36). On the contrary, the SYNTAX
core lost even the slight predictive ability for patients
ndergoing CABG, as shown by the C-index value of 0.53.
ecause the grafts are bypassed downstream of the lesions in
ABG surgery, angiographic complexity might have little
with the lowest (Low), intermediate (Int), and highest (High) SYNTAX (Syn-
ceiving bare-metal stent (A) and drug-eluting stent (C). Three-year event
n according to the SYNTAX score tertile groups in patients receiving bare-tients
nts re
rizatiolinical impact (17,38). Furthermore, in comparison of the
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620scores, the EuroSCORE was more effective in predicting
he risk of MAVE after PCI and CABG and the risk of
ACCE after CABG, whereas the SYNTAX score was
ore effective in predicting the risk of MACCE only after
ES treatment. Accordingly, in another analysis with
ultivariate Cox models, the SYNTAX score was excluded
rom factors predictive of MAVE or MACCE, after ad-
usting for baseline clinical and angiographic characteristics.
In addition to the assessment of predictability, an inter-
ction between the treatment type—whether CABG or
CI—and SYNTAX score tertiles was examined to find its
ole in helping a selection of the appropriate treatment
trategy. A recent SYNTAX trial of patients with multives-
el or ULMCA disease showed that the risk of MACCE
iffered between patients in the highest SYNTAX score
ertile who underwent PCI or CABG, but no differences
ere found in patients in the lowest or intermediate tertiles
17). Consequently, the interaction test between the treat-
ent type and SYNTAX score groups was statistically
Table 3. Comparison of Discrimination, Calibration, and Global Fit Models
Models
Death, Q-Wave MI, or Stro
Discrimination
C-Index
(95% CI) AIC
Overall patients
SYNTAX score 0.59 (0.55–0.64) 1,993.9
EuroSCORE 0.67 (0.62–0.71) 1,949.6
SYNTAX score/EuroSCORE 0.68 (0.63–0.72) 1,948.5
Tertile of SYNTAX score 0.58 (0.54–0.63) 1,994.3
PCI patients receiving any stent
SYNTAX score 0.63 (0.57–0.70) 765.4
EuroSCORE 0.64 (0.56–0.72) 752.5
SYNTAX score/EuroSCORE 0.67 (0.59–0.74) 750.2
Tertile of SYNTAX score 0.60 (0.54–0.67) 767.8
PCI patients receiving BMS
SYNTAX score 0.61 (0.50–0.71) 163.7
EuroSCORE 0.52 (0.36–0.69) 164.1
SYNTAX score/EuroSCORE 0.59 (0.46–0.72) 165.3
Tertile of SYNTAX score 0.61 (0.49–0.73) 163.6
PCI patients receiving DES
SYNTAX score 0.66 (0.58–0.74) 532.3
EuroSCORE 0.68 (0.60–0.77) 517.5
SYNTAX score/EuroSCORE 0.71 (0.63–0.79) 515.7
Tertile of SYNTAX score 0.63 (0.55–0.71) 534.2
CABG patients
SYNTAX score 0.53 (0.47–0.59) 1,040.2
EuroSCORE 0.67 (0.61–0.73) 1,010.7
SYNTAX score/EuroSCORE 0.68 (0.62–0.73) 1,012.7
Tertile of SYNTAX score 0.54 (0.49–0.60) 1,040.8
AIC Akaike Information Criterion; BMS bare-metal stent(s); CI confidence interval; DES druignificant. This study suggested that the SYNTAX score sould be used to assist physicians in selecting an optimal
reatment strategy, depending on the value of the score (17).
owever, in our study, the interaction between type of
reatment and SYNTAX score tertile was not significant
ith regard to the risk of MAVE or MACCE. In our
urvival analysis, the pattern of differential outcomes be-
ween PCI and CABG was not significantly influenced
ccording to the SYNTAX score tertiles. This finding
ndicates that the SYNTAX score might not be validated as
useful guidance to select an appropriate strategy in
LMCA revascularization.
The limited applicability of the SYNTAX score in our
tudy might be explained with several possible mechanisms.
irstly, a significant number of predictors might be based
ore on clinical and procedural factors than on angio-
raphic morphologies. In several previous risk models,
linical risk profiles were more closely related with the
mmediate and long-term outcomes after either PCI or
ABG (23,32,33). In fact, the partial role of SYNTAX
diction of Outcomes
Death, Q-Wave MI, Stroke, or TVR
libration
pe of the
r Predictor
Discrimination
Calibration
Slope of the
Linear Predictor
C-Index
(95% CI) AIC
1.12 0.53 (0.48–0.55) 3,511.0 0.93
1.02 0.57 (0.53–0.60) 3,493.9 1.09
1.00 0.57 (0.53–0.60) 3,495.7 1.02
1.00 0.52 (0.48–0.55) 3,512.0 0.37
1.07 0.57 (0.52–0.61) 1,874.3 1.00
1.06 0.53 (0.48–0.58) 1,876.5 1.16
1.02 0.57 (0.52–0.61) 1,874.6 0.97
1.05 0.55 (0.50–0.59) 1,876.6 0.84
0.81 0.48 (0.40–0.56) 374.9 0.34
0.41 0.53 (0.42–0.56) 373.6 1.35
0.46 0.53 (0.42–0.63) 375.5 0.59
0.76 0.54 (0.47–0.61) 375.1 0.62
1.15 0.60 (0.55–0.65) 1,333.4 1.09
1.05 0.53 (0.47–0.58) 1,340.1 0.88
0.96 0.60 (0.55–0.65) 1,334.8 0.97
0.94 0.58 (0.53–0.63) 1,333.9 0.97
0.78 0.51 (0.46–0.57) 1,301.3 0.89
0.99 0.64 (0.58–0.69) 1,277.2 1.05
0.99 0.64 (0.58–0.69) 1,279.1 1.01
0.78 0.52 (0.43–0.57) 1,302.6 0.50
g stent(s); TVR target vessel revascularization; other abbreviations as in Table 1.for Pre
ke
Ca
Slo
Lineacore in predicting MAVE in our study might be attributed
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621o the comorbidities in patients having extensive coronary
rtery stenosis. However, the SYNTAX score was concep-
ually created by a combination and modification of previous
ngiographic scoring systems, which had not themselves
een validated on the patient cohort. Therefore, the
YNTAX score might have inherent limitations in its
pplicability to real-world practice. Secondly, significant
nterobserver variation in SYNTAX score, attributable to
ifferences in measurements of complex coronary anato-
ies, might have resulted in heterogeneous outcomes across
tudies. For example, the scoring system considers “count-
ble segment” as a lesion 1.5 mm in diameter; visual
ngiographic interpretation might introduce a measurement
ias. Furthermore, “angiographic-importance,” as deter-
ined by vessel size, might not always reflect “clinical-
mportance,” as determined by the requirement for revascu-
arization. As a result, the interobserver variability of scores
Table 4. Multivariate Predictors of Outcomes
Outcomes Hazard Ratio 95% CI p Value
Death, Q-wave MI, or stroke
Overall patients
EuroSCORE 1.25 1.16–1.34 0.001
Chronic lung disease 2.14 1.07–4.29 0.032
Chronic renal failure 2.67 1.54–4.63 0.001
Atrial ﬁbrillation 2.21 1.11–4.42 0.024
PCI patients
EuroSCORE 1.17 1.05–1.31 0.004
Prior congestive heart failure 3.86 1.58–9.44 0.003
Chronic renal failure 6.15 2.90–13.01 0.001
CABG patients
EuroSCORE 1.27 1.16–1.39 0.001
Diabetes mellitus 1.76 1.13–2.75 0.013
Chronic lung disease 4.03 1.79–9.05 0.001
Prior cerebrovascular disease 2.36 1.29–4.31 0.005
Hyperlipidemia 0.60 0.36–0.99 0.043
Death, Q-wave MI, stroke, or TVR
Overall patients
EuroSCORE 1.10 1.04–1.16 0.001
CABG 0.71 0.54–0.92 0.010
Chronic renal failure 2.32 1.40–3.85 0.001
Prior cerebrovascular disease 1.58 1.08–2.33 0.020
Use of intra-aortic balloon pump 2.00 1.09–3.64 0.024
PCI patients
Prior congestive heart failure 2.98 1.44–6.16 0.003
Use of intra-aortic balloon pump 2.25 1.23–4.10 0.008
Chronic renal failure 4.17 2.27–7.64 0.001
CABG patients
EuroSCORE 1.22 1.12–1.33 0.001
Chronic lung disease 2.52 1.15–5.49 0.021
Prior MI 1.76 1.06–2.94 0.030
Prior cerebrovascular disease 2.32 1.36–3.99 0.002
Abbreviations as in Tables 1 and 3.ight be fairly exaggerated in patients with multiple coro- pary lesions. Finally, the disparities in follow-up duration,
atient characteristics, and practice pattern across the vari-
us study cohorts might lead to the different results.
lthough the previous studies showing a strong predictabil-
ty of the SYNTAX score had follow-up duration of 2
ears (17,34), in our present study, more than 95% of
atients were followed up for 3 years. Indeed, we found that
he event curves for MACCE, when PCI and CABG were
ompared, gradually diverged beyond 1 year in the
YNTAX score groups. In addition, a higher rate of
ngiographic follow-up in our study might inflate the need
f repeat revascularization, especially for patients undergo-
ng PCI (10).
It is noteworthy, however, that the SYNTAX score is still
novel method to systemically represent angiographic
omplexity of each patient with a single numerical value. No
revious angiographic scoring system can represent a
atient-based morphology but a lesion-based morphology
34). Therefore, to improve its clinical performance while
aintaining the unique advantage, our study suggested a
odification of the SYNTAX score with consideration of
linical risk profiles. When the EuroSCORE was merged
ith the SYNTAX score in our analysis of discrimination
nd calibration, the C-index for MAVE was somewhat
mproved in PCI and CABG groups.
Several limitations of the present study should be addressed.
irst, the current prediction model was derived from large-
olume referral hospitals in 1 Asian country. This might have
ffected the applicability of the risk score (25), indicating a
eed for further studies on calibration and discrimination
bility of the SYNTAX score in geographically and temporally
ifferent populations. However, because our study included a
ide range of patients who received BMS, DES, and contem-
orary CABG, our validation model might have been adequate
or testing the effectiveness of risk scores in patients undergoing
urrent revascularization therapies. Second, our validation co-
ort excluded patients with acute ST-segment elevation MI or
ardiogenic shock who underwent emergency procedures. Pre-
ious risk models for patients undergoing PCI have shown
ifferent discriminative powers when elective and emergency
rocedures were compared (33). Third, our study was retro-
pectively performed for a selected population. Therefore,
lthough angiographic analysis is independently performed in
he core laboratory, a bias in assessing lesion morphology
ight be introduced. For instance, the decision of the angiog-
apher about the presence of “disease” in each segment might
e influenced by the procedures captured on the analytic
ngiograms. Furthermore, we need more tests to assess the
eliability of measurements across diverse patient subsets.
inally, because our study exclusively enrolled patients with
LMCA stenosis, the validity of the SYNTAX score for other
atients and lesions should be further examined in other
rospective design studies.
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622onclusions
ur validation test of the SYNTAX score suggested that this
ovel scoring model to present angiographic complexity might
lay a partial role in predicting long-term outcomes after PCI,
ot after CABG, in patients with ULMCA stenosis. An
ntegration of a clinical risk prediction based on physician
nowledge and experience and patient clinical characteristics
ight be required for better clinical performance of the
YNTAX score. Therefore, additional research on a useful risk
tratification model is still warranted for the widespread and
ystemic application of a validated risk score.
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